ORKA FY 2019 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$89,000

Operating Income

-$6M

Net Income

-$5M

EPS (Diluted)

$-49.79

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$9M

Total Liabilities

$926,000

Stockholders' Equity

$8M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$89,000	-$22,000	-304.5%
Operating Income	-$6M	-$8M	+28.4%
Net Income	-$5M	-$8M	+30.9%